Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,205 | 5,235 | 1,285 | 941 | 2,530 |
| Receivables | 193 | 49 | 49 | 46 | 359 |
| TOTAL | $10,809 | $7,833 | $1,777 | $1,766 | $3,456 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8,742 | 8,642 | 3,201 | 3,101 | 3,101 |
| TOTAL | $8,742 | $8,642 | $3,201 | $3,101 | $3,101 |
| Total Assets | $19,551 | $16,475 | $4,978 | $4,867 | $6,557 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Accounts payable and accrued liabilities | 8,440 | 7,341 | 2,865 | 5,394 | 3,211 |
| Accrued Expenses | 1,115 | 1,405 | 3,318 | 908 | 1,340 |
| TOTAL | $10,555 | $9,746 | $7,833 | $7,952 | $6,201 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,194 | 4,194 | 5,194 | 5,194 | 5,194 |
| TOTAL | $4,194 | $4,194 | $5,194 | $5,194 | $5,194 |
| Total Liabilities | $14,749 | $13,940 | $13,027 | $13,146 | $11,395 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 148 | 28 | 24 | 1 | 1 |
| Common Shares | 3 | 16 | N/A | 21 | 21 |
| Retained earnings | -102,046 | -96,207 | -91,094 | -86,359 | -81,957 |
| Other shareholders' equity | 990 | 922 | 759 | 1,373 | 647 |
| TOTAL | $4,802 | $2,535 | $-8,049 | $-8,279 | $-4,838 |
| Total Liabilities And Equity | $19,551 | $16,475 | $4,978 | $4,867 | $6,557 |